Cargando…
Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma
Despite intensive research efforts, pancreatic ductal adenocarcinoma is still regarded as an aggressive and life-limiting malignancy. Combination chemotherapy regimens that underpin the current treatment approach in the advanced setting have led to incremental survival gains in recent years but have...
Autores principales: | Fong, Caroline Y. K., Burke, Emma, Cunningham, David, Starling, Naureen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748185/ https://www.ncbi.nlm.nih.gov/pubmed/31582971 http://dx.doi.org/10.1155/2019/7135437 |
Ejemplares similares
-
Contemporary Tailored Oncology Treatment of Biliary Tract Cancers
por: Turkes, Fiona, et al.
Publicado: (2019) -
Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma
por: Hu, Xi, et al.
Publicado: (2021) -
Role of erlotinib in the management of pancreatic cancer
por: Starling, Naureen, et al.
Publicado: (2006) -
Targeting Vascular Endothelial Growth Factor in Oesophagogastric Cancer: A Review of Progress to Date and Immunotherapy Combination Strategies
por: Butters, Oliver, et al.
Publicado: (2019) -
A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma
por: Tesfaye, Anteneh A., et al.
Publicado: (2019)